This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
D-Wave Pushes Quantum-AI Frontier but Faces Pressure From IBM, Google
by Urmimala Biswas
D-Wave debuts a PyTorch-integrated Quantum AI toolkit, but IBM and Google's hardware breakthroughs keep the pressure on.
QBTS or RGTI: Which Stock Will Win As IBM, MSFT, NVIDIA Back Quantum?
by Urmimala Biswas
QBTS surges ahead of RGTI as IBM, Microsoft and NVIDIA fuel quantum momentum, with analysts seeing stronger upside for D-Wave.
Quantum to Oil: Should You Keep an Eye on D-Wave & ExxonMobil Stocks?
by Nilanjan Banerjee
XOM and QBTS are exploring quantum tech to boost efficiency and tackle complex challenges across energy and beyond.
The Zacks Analyst Blog Highlights Quantum Computing, IonQ, Rigetti Computing, D-Wave Quantum and NVIDIA
by Zacks Equity Research
Quantum Computing Inc. soars over 2000%, sparking comparisons to NVIDIA, but its small revenue base makes the stock a high-risk bet.
QUBT or QBTS: Which Quantum Stock Wins on Cash Strength and Roadmap?
by Urmimala Biswas
Though both quantum stocks are on bold growth paths, QBTS outpaces QUBT with bigger cash reserves, revenue momentum and analyst upside.
Can QUBT Become the Next NVIDIA, and Should You Buy the Stock?
by Tirthankar Chakraborty
QCi shares surged over 2000% as its photonic quantum push, NASA ties, and Arizona chip foundry fuel investor attention.
Short-Term Pain, Long-Term Gain? 4 Quantum Stocks to Watch
by Urmimala Biswas
IonQ, D-Wave, Rigetti and QUBT report steep Q2 losses but strengthen cash positions with major fundraising to fuel quantum growth.
Will Chiplets Give Rigetti the Edge in the Race to Quantum Scale?
by Harshit Gupta
RGTI's new chiplet-powered system halves error rates, boosts fidelity, and sets the stage for 100+ qubits by 2025-end.
QBTS Secures $819M Cash War Chest for Future R&D: Upside Ahead?
by Urmimala Biswas
QBTS builds a record $819M cash pile to fuel R&D, expand globally and pursue acquisitions, with analysts eyeing near-term upside.
RGTI Q2 Secures Funding Amid Weak Sales: Time to Buy, Hold or Sell?
by Harshit Gupta
Rigetti posts weaker Q2 sales but secures $350 million, ending with $571.6 million in cash and no debt to fuel its quantum ambitions.